UNIGE document Scientific Article
previous document  unige:56001  next document
add to browser collection

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

Beldjord, Kheira
Chevret, Sylvie
Asnafi, Vahid
Huguet, Françoise
Boulland, Marie-Laure
Leguay, Thibaut
Thomas, Xavier
Cayuela, Jean-Michel
show hidden authors show all authors [1 - 25]
Published in Blood. 2014, vol. 123, no. 24, p. 3739-49
Abstract With intensified pediatric-like therapy and genetic disease dissection, the field of adult acute lymphoblastic leukemia (ALL) has evolved recently. In this new context, we aimed to reassess the value of conventional risk factors with regard to new genetic alterations and early response to therapy, as assessed by immunoglobulin/T-cell receptor minimal residual disease (MRD) levels. The study was performed in 423 younger adults with Philadelphia chromosome-negative ALL in first remission (265 B-cell precursor [BCP] and 158 T-cell ALL), with cumulative incidence of relapse (CIR) as the primary end point. In addition to conventional risk factors, the most frequent currently available genetic alterations were included in the analysis. A higher specific hazard of relapse was independently associated with postinduction MRD level ≥10(-4) and unfavorable genetic characteristics (ie, MLL gene rearrangement or focal IKZF1 gene deletion in BCP-ALL and no NOTCH1/FBXW7 mutation and/or N/K-RAS mutation and/or PTEN gene alteration in T-cell ALL). These 2 factors allowed definition of a new risk classification that is strongly associated with higher CIR and shorter relapse-free and overall survival. These results indicate that genetic abnormalities are important predictors of outcome in adult ALL not fully recapitulated by early response to therapy. Patients included in this study were treated in the multicenter GRAALL-2003 and GRAALL-2005 trials. Both trials were registered at http://www.clinicaltrials.gov as #NCT00222027 and #NCT00327678, respectively.
Keywords AdolescentAdultDNA Mutational AnalysisFemaleHumansMaleMiddle AgedMulticenter Studies as TopicNeoplasm, ResidualPrecursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/genetics/mortality/pathologyPrognosisRecurrenceRetrospective StudiesSurvival AnalysisTumor Markers, Biological/geneticsYoung Adult
PMID: 24740809
Full text
Article (Published version) (1 MB) - document accessible for UNIGE members only Limited access to UNIGE
Research groups SAKK
Groupe Lecompte Thomas Pierre (hématologie) (918)
(ISO format)
BELDJORD, Kheira et al. Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. In: Blood, 2014, vol. 123, n° 24, p. 3739-49. doi: 10.1182/blood-2014-01-547695 https://archive-ouverte.unige.ch/unige:56001

430 hits

1 download


Deposited on : 2015-05-04

Export document
Format :
Citation style :